{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T21:41:56Z","timestamp":1788903716953,"version":"build-2803163510"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,9]],"date-time":"2024-11-09T00:00:00Z","timestamp":1731110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,9]],"date-time":"2024-11-09T00:00:00Z","timestamp":1731110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82101616"],"award-info":[{"award-number":["82101616"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"DOI":"10.1038\/s41398-024-03176-4","type":"journal-article","created":{"date-parts":[[2024,11,9]],"date-time":"2024-11-09T13:54:05Z","timestamp":1731160445000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Ketamine attenuates kidney damage and depression-like behaviors in mice with cisplatin-induced acute kidney injury"],"prefix":"10.1038","volume":"14","author":[{"given":"Tianwen","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruijuan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8892-0439","authenticated-orcid":false,"given":"Kenji","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoyu","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,9]]},"reference":[{"key":"3176_CR1","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1016\/S0140-6736(15)00344-X","volume":"386","author":"L Yang","year":"2015","unstructured":"Yang L, Xing G, Wang L, Wu Y, Li S, Xu G, et al. Acute kidney injury in China: a cross-sectional survey. Lancet (London, England). 2015;386:1465\u201371.","journal-title":"Lancet (London, England)"},{"key":"3176_CR2","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.semnephrol.2020.08.001","volume":"40","author":"J Huang","year":"2020","unstructured":"Huang J, Xu D, Yang L. Acute kidney injury in Asia: disease burden. Sem Nephrology. 2020;40:443\u201355.","journal-title":"Sem Nephrology"},{"key":"3176_CR3","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/ki.2011.339","volume":"81","author":"K Singbartl","year":"2012","unstructured":"Singbartl K, Kellum JA. AKI in the ICU: definition, epidemiology, risk stratification, and outcomes. Kidney Int. 2012;81:819\u201325.","journal-title":"Kidney Int"},{"key":"3176_CR4","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1007\/s00134-015-3934-7","volume":"41","author":"EA Hoste","year":"2015","unstructured":"Hoste EA, Bagshaw SM, Bellomo R, Cely CM, Colman R, Cruz DN, et al. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med. 2015;41:1411\u201323.","journal-title":"Intensive Care Med"},{"key":"3176_CR5","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/ki.2013.77","volume":"84","author":"S Palmer","year":"2013","unstructured":"Palmer S, Vecchio M, Craig JC, Tonelli M, Johnson DW, Nicolucci A, et al. Prevalence of depression in chronic kidney disease: systematic review and meta-analysis of observational studies. Kidney Int. 2013;84:179\u201391.","journal-title":"Kidney Int"},{"key":"3176_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2022.101762","volume":"82","author":"X Tang","year":"2022","unstructured":"Tang X, Han YP, Chai YH, Gong HJ, Xu H, Patel I, et al. Association of kidney function and brain health: a systematic review and meta-analysis of cohort studies. Ageing Res Rev. 2022;82:101762.","journal-title":"Ageing Res Rev"},{"key":"3176_CR7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1159\/000449474","volume":"135","author":"RA Balogun","year":"2017","unstructured":"Balogun RA, Omotoso BA, Xin W, Ma JZ, Scully KW, Arogundade FA, et al. Major depression and long-term outcomes of acute kidney injury. Nephron. 2017;135:23\u201330.","journal-title":"Nephron"},{"key":"3176_CR8","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1111\/pcn.12902","volume":"73","author":"K Hashimoto","year":"2019","unstructured":"Hashimoto K. Rapid-acting antidepressant ketamine, its metabolites and other candidates: a historical overview and future perspective. Psychiatry Clin Neurosci. 2019;73:613\u201327.","journal-title":"Psychiatry Clin Neurosci"},{"key":"3176_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2020.113935","volume":"177","author":"K Hashimoto","year":"2020","unstructured":"Hashimoto K. Molecular mechanisms of the rapid-acting and long-lasting antidepressant actions of (R)-ketamine. Biochem Pharmacol. 2020;177:113935.","journal-title":"Biochem Pharmacol"},{"key":"3176_CR10","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/s41380-021-01121-1","volume":"27","author":"Y Wei","year":"2022","unstructured":"Wei Y, Chang L, Hashimoto K. Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor. Mol Psychiatry. 2022;27:559\u201373.","journal-title":"Mol Psychiatry"},{"key":"3176_CR11","doi-asserted-by":"crossref","unstructured":"Hashimoto K, Zhao M, Zhu T, Wang X, Yang J Ketamine and its two enantiomers in anesthesiology and psychiatry: a historical review and future directions. J Anes Transl Med. 2024:3:65\u2013132.","DOI":"10.1016\/j.jatmed.2024.07.001"},{"key":"3176_CR12","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","volume":"63","author":"CA Zarate Jr","year":"2006","unstructured":"Zarate CA Jr, Singh JB, Carlson PJ, Brutsche NE, Ameli R, et al. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry. 2006;63:856\u201364.","journal-title":"Arch Gen Psychiatry"},{"key":"3176_CR13","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1038\/s41380-018-0256-5","volume":"25","author":"M Fava","year":"2020","unstructured":"Fava M, Freeman MP, Flynn M, Judge H, Hoeppner BB, Cusin C, et al. Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD). Mol Psychiatry. 2020;25:1592\u2013603.","journal-title":"Mol Psychiatry"},{"key":"3176_CR14","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s00213-019-05346-5","volume":"237","author":"A Fujita","year":"2020","unstructured":"Fujita A, Fujita Y, Pu Y, Chang L, Hashimoto K. MPTP-induced dopaminergic neurotoxicity in mouse brain is attenuated after subsequent intranasal administration of (R)-ketamine: a role of TrkB signaling. Psychopharmacol. 2020;237:83\u201392.","journal-title":"Psychopharmacol"},{"key":"3176_CR15","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.brainresbull.2021.10.013","volume":"177","author":"X Wang","year":"2021","unstructured":"Wang X, Chang L, Tan Y, Qu Y, Shan J, Hashimoto K. (R)-ketamine ameliorates the progression of experimental autoimmune encephalomyelitis in mice. Brain Res Bull. 2021;177:316\u201323.","journal-title":"Brain Res Bull"},{"key":"3176_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2022.105635","volume":"165","author":"X Wang","year":"2022","unstructured":"Wang X, Chang L, Wan X, Tan Y, Qu Y, Shan J, et al. (R)-ketamine ameliorates demyelination and facilitates remyelination in cuprizone-treated mice: a role of gut-microbiota-brain axis. Neurobiol Dis. 2022;165:105635.","journal-title":"Neurobiol Dis"},{"key":"3176_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2020.172904","volume":"191","author":"Z Xiong","year":"2020","unstructured":"Xiong Z, Chang L, Qu Y, Pu Y, Wang S, Fujita Y, et al. Neuronal brain injury after cerebral ischemic stroke is ameliorated after subsequent administration of (R)-ketamine, but not (S)-ketamine. Pharmacol Biochem Behav. 2020;191:172904.","journal-title":"Pharmacol Biochem Behav"},{"key":"3176_CR18","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.pnpbp.2007.07.027","volume":"32","author":"LS Garcia","year":"2008","unstructured":"Garcia LS, Comim CM, Valvassori SS, R\u00e9us GZ, Barbosa LM, Andreazza AC, et al. Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32:140\u20134.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"3176_CR19","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nature10130","volume":"475","author":"AE Autry","year":"2011","unstructured":"Autry AE, Adachi M, Nosyreva E, Na ES, Los MF, Cheng PF, et al. NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature. 2011;475:91\u20135.","journal-title":"Nature"},{"key":"3176_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2015.136","volume":"5","author":"C Yang","year":"2015","unstructured":"Yang C, Shirayama Y, Zhang JC, Ren Q, Yao W, Ma M, et al. R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects. Transl Psychiatry. 2015;5:e632.","journal-title":"Transl Psychiatry"},{"key":"3176_CR21","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.biopsych.2017.05.016","volume":"83","author":"C Yang","year":"2018","unstructured":"Yang C, Ren Q, Qu Y, Zhang JC, Ma M, Dong C, et al. Mechanistic target of rapamycin-independent antidepressant effects of (R)-ketamine in a social defeat stress model. Biol Psychiatry. 2018;83:18\u201328.","journal-title":"Biol Psychiatry"},{"key":"3176_CR22","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1038\/s41593-021-00868-8","volume":"24","author":"JW Kim","year":"2021","unstructured":"Kim JW, Autry AE, Na ES, Adachi M, Bj\u00f6rkholm C, Kavalali ET, et al. Sustained effects of rapidly acting antidepressants require BDNF-dependent MeCP2 phosphorylation. Nat Neurosci. 2021;24:1100\u20139.","journal-title":"Nat Neurosci"},{"key":"3176_CR23","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1038\/s41380-021-01377-7","volume":"27","author":"W Yao","year":"2022","unstructured":"Yao W, Cao Q, Luo S, He L, Yang C, Chen J, et al. Microglial ERK-NRBP1-CREB-BDNF signaling in sustained antidepressant actions of (R)-ketamine. Mol Psychiatry. 2022;27:1618\u201329.","journal-title":"Mol Psychiatry"},{"key":"3176_CR24","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s00213-015-4128-2","volume":"233","author":"WX Liu","year":"2016","unstructured":"Liu WX, Wang J, Xie ZM, Xu N, Zhang GF, Jia M, et al. Regulation of glutamate transporter 1 via BDNF-TrkB signaling plays a role in the anti-apoptotic and antidepressant effects of ketamine in chronic unpredictable stress model of depression. Psychopharmacology (Berl). 2016;233:405\u201315.","journal-title":"Psychopharmacology (Berl)"},{"key":"3176_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2022.109383","volume":"225","author":"XH Tang","year":"2023","unstructured":"Tang XH, Diao YG, Ren ZY, Zang YY, Zhang GF, Wang XM, et al. A role of GABAA receptor \u03b11 subunit in the hippocampus for rapid-acting antidepressant-like effects of ketamine. Neuropharmacology. 2023;225:109383.","journal-title":"Neuropharmacology"},{"key":"3176_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2022.109219","volume":"218","author":"JC Zhang","year":"2022","unstructured":"Zhang JC, Yao W, Hashimoto K. Arketamine, a new rapid-acting antidepressant: a historical review and future directions. Neuropharmacology. 2022;218:109219.","journal-title":"Neuropharmacology"},{"key":"3176_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2022.109305","volume":"222","author":"K Zhang","year":"2023","unstructured":"Zhang K, Yao Y, Hashimoto K. Ketamine and its metabolites: potential as novel treatments for depression. Neuropharmacology. 2023;222:109305.","journal-title":"Neuropharmacology"},{"key":"3176_CR28","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1038\/s41380-023-02288-5","volume":"29","author":"C Huang","year":"2024","unstructured":"Huang C, Wu Z, Wang D, Qu Y, Zhang J, Jiang R, et al. Myelin-associated oligodendrocytic basic protein-dependent myelin repair confers the long-lasting antidepressant effect of ketamine. Mol Psychiatry. 2024;29:1741\u201353.","journal-title":"Mol Psychiatry"},{"key":"3176_CR29","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.brainresbull.2022.02.004","volume":"182","author":"L Chang","year":"2022","unstructured":"Chang L, Wei Y, Hashimoto K. Brain-gut-microbiota axis in depression: a historical overview and future directions. Brain Res Bull. 2022;182:44\u201356.","journal-title":"Brain Res Bull"},{"key":"3176_CR30","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.brainresbull.2022.02.008","volume":"182","author":"Y Wei","year":"2022","unstructured":"Wei Y, Wang T, Liao L, Fan X, Chang L, Hashimoto K. Brain-spleen axis in health and diseases: a review and future perspective. Brain Res Bull. 2022;182:130\u201340.","journal-title":"Brain Res Bull"},{"key":"3176_CR31","doi-asserted-by":"publisher","first-page":"4325","DOI":"10.1007\/s00213-015-4062-3","volume":"232","author":"JC Zhang","year":"2015","unstructured":"Zhang JC, Yao W, Dong C, Yang C, Ren Q, Ma M, et al. Comparison of ketamine, 7,8-dihydroxyflavone, and ANA-12 antidepressant effects in the social defeat stress model of depression. Psychopharmacology. 2015;232:4325\u201335.","journal-title":"Psychopharmacology"},{"key":"3176_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2015.157","volume":"5","author":"Q Ren","year":"2015","unstructured":"Ren Q, Ma M, Yang C, Zhang JC, Yao W, Hashimoto K. BDNF-TrkB signaling in the nucleus accumbens shell of mice has key role in methamphetamine withdrawal symptoms. Transl Psychiatry. 2015;5:e666.","journal-title":"Transl Psychiatry"},{"key":"3176_CR33","doi-asserted-by":"crossref","unstructured":"Pu Y, Huang R, Chai L, Yang H, Wang D, Wei Z. et al. Multimode evaluating the fluctuation of lipid droplets polarity in acute kidney injury and tumor models. Sensors Actuators B Chem. 2023:380:133343.","DOI":"10.1016\/j.snb.2023.133343"},{"key":"3176_CR34","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.bbi.2020.12.032","volume":"94","author":"Y Pu","year":"2021","unstructured":"Pu Y, Tan Y, Qu Y, Chang L, Wang S, Wei Y, et al. A role of the subdiaphragmatic vagus nerve in depression-like phenotypes in mice after fecal microbiota transplantation from Chrna7 knock-out mice with depression-like phenotypes. Brain Behav Immun. 2021;94:318\u201326.","journal-title":"Brain Behav Immun"},{"key":"3176_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-022-01993-z","volume":"12","author":"Y Pu","year":"2022","unstructured":"Pu Y, Zhang Q, Tang Z, Lu C, Wu L, Zhong Y, et al. Fecal microbiota transplantation from patients with rheumatoid arthritis causes depression-like behaviors in mice through abnormal T cells activation. Transl Psychiatry. 2022;12:223.","journal-title":"Transl Psychiatry"},{"key":"3176_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2022.173448","volume":"219","author":"Y Pu","year":"2022","unstructured":"Pu Y, He Y, Zhao X, Zhang Q, Wen J, Hashimoto K, et al. Depression-like behaviors in mouse model of Sj\u00f6gren\u2019s syndrome: a role of gut-microbiota-brain axis. Pharmacol Biochem Behav. 2022;219:173448.","journal-title":"Pharmacol Biochem Behav"},{"key":"3176_CR37","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1007\/s00213-023-06348-0","volume":"240","author":"Y Pu","year":"2023","unstructured":"Pu Y, Wu Q, Zhang Q, Huang T, Wen J, Wei L, et al. Mesenchymal stem-cell-derived microvesicles ameliorate MPTP-induced neurotoxicity in mice: a role of the gut\u2013microbiota\u2013brain axis. Psychopharmacology. 2023;240:1103\u201318.","journal-title":"Psychopharmacology"},{"key":"3176_CR38","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s40620-017-0392-z","volume":"31","author":"S Manohar","year":"2018","unstructured":"Manohar S, Leung N. Cisplatin nephrotoxicity: a review of the literature. J Nephrol. 2018;31:15\u201325.","journal-title":"J Nephrol"},{"key":"3176_CR39","doi-asserted-by":"publisher","first-page":"1532.","DOI":"10.3390\/ijms23031532","volume":"23","author":"S Dasari","year":"2022","unstructured":"Dasari S, Njiki S, Mbemi A, Yedjou CG, Tchounwou PB. Pharmacological effects of cisplatin combination with natural products in cancer chemotherapy. Int J Mol Sci. 2022;23:1532.","journal-title":"Int J Mol Sci"},{"key":"3176_CR40","doi-asserted-by":"publisher","first-page":"5265","DOI":"10.1111\/jcmm.13762","volume":"22","author":"N Endlich","year":"2018","unstructured":"Endlich N, Lange T, Kuhn J, Klemm P, Kotb AM, Siegerist F, et al. BDNF: mRNA expression in urine cells of patients with chronic kidney disease and its role in kidney function. J Cell Mol Med. 2018;22:5265\u201377.","journal-title":"J Cell Mol Med"},{"key":"3176_CR41","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13098-023-00991-5","volume":"15","author":"CY Hsu","year":"2023","unstructured":"Hsu CY, Sheu WH, Lee IT. Brain-derived neurotrophic factor associated with kidney function. Diabetol Metab Syndr. 2023;15:16.","journal-title":"Diabetol Metab Syndr"},{"key":"3176_CR42","doi-asserted-by":"publisher","first-page":"63.","DOI":"10.1186\/s12882-018-0852-2","volume":"19","author":"YS Tao","year":"2018","unstructured":"Tao YS, Piao SG, Jin YS, Jin JZ, Zheng HL, Zhao HY, et al. Expression of brain-derived neurotrophic factor in kidneys from normal and cyclosporine-treated rats. BMC Nephrol. 2018;19:63.","journal-title":"BMC Nephrol"},{"key":"3176_CR43","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s00429-006-0098-9","volume":"211","author":"O Garc\u00eda-Su\u00e1rez","year":"2006","unstructured":"Garc\u00eda-Su\u00e1rez O, Gonz\u00e1lez-Mart\u00ednez T, Perez-Perez M, Germana A, Blanco-G\u00e9laz MA, Monjil DF, et al. Expression of the neurotrophin receptor TrkB in the mouse liver. Anat Embryol (Berl). 2006;211:465\u201373.","journal-title":"Anat Embryol (Berl)"},{"key":"3176_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2023.1268648","volume":"14","author":"N Grzelak","year":"2023","unstructured":"Grzelak N, Kaczmarek D, Mr\u00f3wczy\u0144ski W. Comparison of the effects of BDNF\/TRKB signalling on metabolic biomarkers in the liver of sedentary and trained rats with normal and knockout BDNF genotypes. Front Physiol. 2023;14:1268648.","journal-title":"Front Physiol"},{"key":"3176_CR45","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.14647","volume":"35","author":"X Quan","year":"2023","unstructured":"Quan X, Chen W, Liang C, Jia Y, Wang Y, Luo H, et al. Downregulation of BDNF-TrkB signaling may contribute to the colonic motility disorders in mice with streptozocin-induced diabetes. Neurogastroenterol Motil. 2023;35:e14647.","journal-title":"Neurogastroenterol Motil"},{"key":"3176_CR46","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s00441-004-0876-8","volume":"316","author":"M P\u00e9rez-P\u00e9rez","year":"2004","unstructured":"P\u00e9rez-P\u00e9rez M, Garc\u00eda-Su\u00e1rez O, Blanco-Gelaz MA, Esteban I, Ciriaco E, Laur\u00e0 R, et al. TrkB mRNA and protein in mouse spleen: structure of the spleen of functionally deficient TrkB mice. Cell Tissue Res. 2004;316:179\u201387.","journal-title":"Cell Tissue Res"},{"key":"3176_CR47","doi-asserted-by":"publisher","unstructured":"Hashimoto K Are \u201cmystical experiences\u201d essential for antidepressant actions of ketamine and the classic psychedelics? Eur Arch Psychiatry Clin Neurosci. 2024. https:\/\/doi.org\/10.1007\/s00406-024-01770-7.","DOI":"10.1007\/s00406-024-01770-7"},{"key":"3176_CR48","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1083\/jcb.200307017","volume":"164","author":"JT Lee","year":"2004","unstructured":"Lee JT, Xu J, Lee JM, Ku G, Han X, Yang DI, et al. Amyloid-beta peptide induces oligodendrocyte death by activating the neutral sphingomyelinase-ceramide pathway. J Cell Biol. 2004;164:123\u201331.","journal-title":"J Cell Biol"},{"key":"3176_CR49","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.pharmthera.2006.04.004","volume":"112","author":"M El Alwani","year":"2006","unstructured":"El Alwani M, Wu BX, Obeid LM, Hannun YA. Bioactive sphingolipids in the modulation of the inflammatory response. Pharmacol Ther. 2006;112:171\u201383.","journal-title":"Pharmacol Ther"},{"key":"3176_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-019-1436-1","volume":"16","author":"NM de Wit","year":"2019","unstructured":"de Wit NM, den Hoedt S, Martinez-Martinez P, Rozemuller AJ, Mulder MT, de Vries HE. Astrocytic ceramide as possible indicator of neuroinflammation. J Neuroinflammation. 2019;16:48.","journal-title":"J Neuroinflammation"},{"key":"3176_CR51","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.1007\/s00415-013-7016-x","volume":"260","author":"M Strupp","year":"2013","unstructured":"Strupp M, Teufel J, Habs M, Feuerecker R, Muth C, van de Warrenburg BP, et al. Effects of acetyl-DL-leucine in patients with cerebellar ataxia: a case series. J Neurol. 2013;260:2556\u201361.","journal-title":"J Neurol"},{"key":"3176_CR52","doi-asserted-by":"publisher","first-page":"e2135841.","DOI":"10.1001\/jamanetworkopen.2021.35841","volume":"4","author":"K Feil","year":"2021","unstructured":"Feil K, Adrion C, Boesch S, Doss S, Giordano I, Hengel H, et al. Safety and efficacy of acetyl-DL-leucine in certain types of cerebellar ataxia: The ALCAT randomized clinical crossover trial. JAMA Netw Open. 2021;4:e2135841.","journal-title":"JAMA Netw Open"},{"key":"3176_CR53","doi-asserted-by":"publisher","first-page":"3864","DOI":"10.1210\/jcem.82.11.4339","volume":"82","author":"G Eisenhofer","year":"1997","unstructured":"Eisenhofer G, Aneman A, Friberg P, Hooper D, F\u00e5ndriks L, Lonroth H, et al. Substantial production of dopamine in the human gastrointestinal tract. J Clin Endocrinol Metab. 1997;82:3864\u201371.","journal-title":"J Clin Endocrinol Metab"},{"key":"3176_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2024.106626","volume":"200","author":"Q Yan","year":"2024","unstructured":"Yan Q, Liu M, Xie Y, Lin Y, Fu P, Pu Y, et al. Kidney-brain axis in the pathogenesis of cognitive impairment. Neurobiol Dis. 2024;200:106626.","journal-title":"Neurobiol Dis"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-024-03176-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-024-03176-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-024-03176-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,10]],"date-time":"2024-11-10T02:01:15Z","timestamp":1731204075000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-024-03176-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,9]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3176"],"URL":"https:\/\/doi.org\/10.1038\/s41398-024-03176-4","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,9]]},"assertion":[{"value":"17 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"KH is the inventor of filed patent applications on \u201cThe use of R-Ketamine in the treatment of psychiatric diseases\u201d, \u201c(S)-norketamine and salt thereof as pharmaceutical\u201d, \u201cR-Ketamine and derivative thereof as prophylactic or therapeutic agent for neurodegeneration disease or recognition function disorder\u201d, \u201cPreventive or therapeutic agent and pharmaceutical composition for inflammatory diseases or bone diseases\u201d, and \u201cR-Ketamine and its derivatives as a preventive or therapeutic agent for a neurodevelopmental disorder\u201d by the Chiba University. KH has also received speakers\u2019 honoraria, consultant fee, or research support from Otsuka. The other authors declare no competing interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The experimental protocol of this study was approved by the Institutional Animal Care and Use Committee of the West China Hospital, Sichuan University (Permission Number 20230807003).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical declarations"}}],"article-number":"468"}}